Pancreatic Cancer Research

ResearcherUniversity of BonnActive in the last 2 years

Peter Duewell

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-0836-6448; OpenAlex author ID A5037139474. Sources: OpenAlex.

Their work

Papers
14 (first author 2, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
19
Papers, trials and grants by year

2013: 1 paper · 2014: 4 papers · 2015: 2 papers · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: 2 papers · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 14

  1. RIG-I agonists promote antigen-spreading and facilitate durable CAR-T responses in pancreatic ductal adenocarcinoma. Co-author DOI 10.1136/jitc-2025-013282↗
  2. IL18 Receptor Signaling Regulates Tumor-Reactive CD8+ T-cell Exhaustion via Activation of the IL2/STAT5/mTOR Pathway in a Pancreatic Cancer Model. Co-author DOI 10.1158/2326-6066.cir-22-0398↗
  3. Systemic but not MDSC-specific IRF4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreatic cancer model. Co-author DOI 10.1007/s00262-020-02605-9↗
  4. Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancer. Last author DOI 10.1186/s40425-019-0778-7↗
  5. Correction to: Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancer. Last author DOI 10.1186/s40425-019-0830-7↗
  6. PD1-CD28 Fusion Protein Enables CD4+ T Cell Help for Adoptive T Cell Therapy in Models of Pancreatic Cancer and Non-hodgkin Lymphoma. Co-author DOI 10.3389/fimmu.2018.01955↗
  7. Prevailing over T cell exhaustion: New developments in the immunotherapy of pancreatic cancer. Co-author DOI 10.1016/j.canlet.2016.02.057↗
  8. Proapoptotic and antiapoptotic proteins of the Bcl-2 family regulate sensitivity of pancreatic cancer cells toward gemcitabine and T-cell-mediated cytotoxicity. Co-author DOI 10.1097/cji.0000000000000073↗
  9. Strategies to relieve immunosuppression in pancreatic cancer. First author DOI 10.2217/imt.15.9↗
  10. RIG-I-like helicases induce immunogenic cell death of pancreatic cancer cells and sensitize tumors toward killing by CD8+ T cells Co-author DOI 10.1038/cdd.2014.161↗
  11. RIG-I-like helicases induce immunogenic cell death of pancreatic cancer cells and sensitize tumors toward killing by CD8(+) T cells. Co-author DOI 10.1038/cdd.2014.96↗
  12. P17. RIG-I-like helicases induce immunogenic cell death of pancreatic cancer cells Last author DOI 10.1186/2051-1426-2-s2-p8↗
  13. Induction of immunogenic cell death by targeting RIG-I-like helicases in pancreatic cancer. First author DOI 10.4161/21624011.2014.955687↗
  14. Therapeutic efficacy of bifunctional siRNA combining TGF-β1 silencing with RIG-I activation in pancreatic cancer. Co-author DOI 10.1158/0008-5472.can-11-3850↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Max M. Schnurr · 12 shared papers, 2013–2026 · strength 0.94
  2. Sebastian Kobold · 7 shared papers, 2014–2026 · strength 0.64
  3. Lars M. König · 4 shared papers, 2019–2026 · strength 0.52
  4. Christian Alexander Bauer · 4 shared papers, 2015–2023 · strength 0.32
  5. Philipp Metzger · 3 shared papers, 2019–2020 · strength 0.27
  6. Anne Marie Senz · 1 shared paper, 2026 · strength 0.26
  7. Thomas Mathias Gress · 2 shared papers, 2016–2023 · strength 0.22
  8. Steffen Ormanns · 2 shared papers, 2016–2020 · strength 0.17
  9. Kirsten Lauber · 2 shared papers, 2015–2020 · strength 0.15
  10. Felix S.R. Picard · 1 shared paper, 2023 · strength 0.15
  11. Malte Buchholz · 1 shared paper, 2023 · strength 0.15
  12. Magdalena Huber · 1 shared paper, 2023 · strength 0.15
  13. Veronika Lutz · 1 shared paper, 2023 · strength 0.15
  14. Corinna Ulrike Keber · 1 shared paper, 2023 · strength 0.15
  15. Felicitas Rataj · 1 shared paper, 2018 · strength 0.08
  16. Jens Thomas Siveke · 2 shared papers, 2014 · strength 0.08
  17. Anna Trauzold · 1 shared paper, 2015 · strength 0.04
  18. Jonathan Ellermeier · 1 shared paper, 2013 · strength 0.03
  19. Gunther Hartmann · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.